Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03739034 · ClinicalTrials.gov registry record · NA

Evaluation of a Lifestyle Medicine Practice

A NA study of Hypertension and Diabetes, sponsored by Ohio University.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT03739034: Completed NA study of Hypertension and Diabetes, sponsored by Ohio University.

NCT03739034 is a NA study of Hypertension and Diabetes that has completed, run by Ohio University. The registered enrollment target is 71 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03739034, a NA study of Hypertension and Diabetes, has completed, sponsored by Ohio University.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

This project will evaluate the success of the PI's lifestyle medicine practice.

Primary Outcome

change in weight

Interventions

  • BEHAVIORAL Lifestyle Medicine

Study Locations (1)

Ohio

  • Ohio University - Athens

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2018-06-28
Est. Completion 2022-03-01
Phase NA
Ohio University

51 total trials

What the finished NCT03739034 record still lists

NCT03739034 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).

The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Lifestyle Medicine is the first listed.

NCT03739034 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT03739034 about?

NCT03739034 is a clinical study titled "Evaluation of a Lifestyle Medicine Practice". This project will evaluate the success of the PI's lifestyle medicine practice.

What is the current status of trial NCT03739034?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2018-06-28. Estimated completion is 2022-03-01.

What conditions does trial NCT03739034 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Cardiovascular Diseases, Overweight and Obesity, Dyslipidemias.

What interventions are being tested in trial NCT03739034?

The interventions under investigation include: Lifestyle Medicine (BEHAVIORAL).

Who is sponsoring clinical trial NCT03739034?

This trial is sponsored by Ohio University, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03739034 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03739034's enrollment target sits among peer trials

71 333rd of 470 higher than 138 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03739034, the US trial registry maintained by the National Library of Medicine. NCT03739034 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.